Comparing Triamcinolone Acetonide Mucoadhesive Films With Licorice Mucoadhesive Films
NCT ID: NCT02075749
Last Updated: 2014-07-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1/PHASE2
60 participants
INTERVENTIONAL
2013-05-31
2014-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Background: Complementary and alternative medicine (CAM) had proven efficacy in pain relief, correction of nutritional status and improving the performance status. However, lack of standardization is the major obstacle for any scientific evaluation of any CAM trial. Mucositis is a major complication of irradiation in head and neck (H\&N) tumors, the addition of chemotherapy to irradiation may enhance this dose limiting problem. Licorice is a strong demulcent that had been effectively used in treatment of peptic ulcer. The main purpose of this study was to compare the therapeutic safety and efficacy of T. and L. mucoadhesive films on oral mucositis in terms of pain control and/or ulcer treatment.
Methods and Materials: the study was a double-blind, randomized prospective trial of two types of mucoadhesive films in the management of oral mucositis occurred during head and neck cancer ( HNC ) radiotherapy. oral mucositis was assessed using a quantitative scale (WHO scales) and symptoms were assessed using visual analogue scales (VAS). 60 patients were enrolled in the study; there were 30 patients in the Triamcinolone (T) and 30 in the Licorice (L) group. In the T- group, patients received triamcinolone acetonide mucoadhesive films containing 1mg of the drug and patients in the L- group received licorice mucoadhesive films, an herbal agent. Data were collected at baseline, then twice a week for 4 weeks.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Efficacy Trial of TV5M01 for Radiation-Induced Mucositis in Head and Neck Cancer Patients.
NCT06875791
Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy
NCT00003610
Rice Bran Supplementation for Radiation-Induced Oral Mucositis in Head and Neck Cancer
NCT07242859
N Acetylcystene in Treatment of Radiotherapy Induced Oral Mucositis in Oral Cancer Patients
NCT07082621
A Trial Looking at Treating Dry Mouth After Radiotherapy for Head and Neck Cancer
NCT02941276
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
triamcinolone acetonide mucoadhesive
30 patients received triamcinolone acetonide mucoadhesive films
Triamcinolone Acetonide
Licorice
30 patients received licorice mucoadhesive films
licorice mucoadhesive films
30 patients received licorice mucoadhesive films
Mucoadhesive film
30 patients received mucoadhesive films without any drug ingredients
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Triamcinolone Acetonide
licorice mucoadhesive films
30 patients received licorice mucoadhesive films
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* men and nonpregnant women
* women of childbearing age who were non-pregnant by pregnancy test and and using medically prescribed contraceptive
* no previous radiation therapy applied in the head and neck
* medically fit for a course of radical radiotherapy
* an ability to remain in the study for its entire duration
Exclusion Criteria
* women of childbearing potential in whom medically prescribed birth control was not used
* concurrent chemotherapy
* history of heavy alcohol or drug abuse judged to be important by the investigator - concomitant therapy with an investigational drug, or cancer chemo therapeutics or immunosuppressive medications
* sensitivity or intolerance to triamcinolone or licorice, lactose or similar formulations
* inability to provide informed consent
* actively bleeding gastric ulcer, severe esophageal reflux
* major surgery, trauma or burns in the preceding 4 weeks
* clinically significant hepatic, neurologic, endocrine, or other systemic disease-making implementation of the protocol or results difficult.
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Isfahan University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mehdi Nasr Isfahani
Dr. Nasr
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Omid ( or Sayyed-O-Shohada) Hospital
Isfahan, Isfahan, Iran
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
393009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.